by jtcir-auto | Jul 29, 2021 | Press Releases
CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of...
by jtcir-auto | Jul 29, 2021 | Press Releases
CHARLESTON, S.C., July 29, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of...
by jtcir-auto | Jun 7, 2021 | Press Releases
– Dr. Levyis a well-established neuroimmunologistwith extensive experience and expertise in the area of neuroimmunology, autoimmune and CNS disorders -Company continues to advance development of its AIM Biologicals pre-clinical program, seeking to develop...
by jtcir-auto | Jun 7, 2021 | Press Releases
– Dr. Levyis a well-established neuroimmunologistwith extensive experience and expertise in the area of neuroimmunology, autoimmune and CNS disorders -Company continues to advance development of its AIM Biologicals pre-clinical program, seeking to develop...
by jtcir-auto | Jun 3, 2021 | Press Releases
CHARLESTON, S.C., June 03, 2021 — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic...
by jtcir-auto | Jun 3, 2021 | Press Releases
CHARLESTON, S.C., June 03, 2021 — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic...